Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SEPT8 |
| Upstream (Parents) |
|---|
| (<<) TNFRSF12A → SEPT8 |
| (<<) PDLIM7 → SEPT8 |
| (<<) CIZ1 → SEPT8 |
| (<<) NBEAL2 → SEPT8 |
| Downstream (Children) |
|---|
| SEPT8 → TNFRSF12A (>>) |
| SEPT8 → PRICKLE3 (>>) |
| SEPT8 → MMP15 (>>) |
| SEPT8 → CLIC3 (>>) |
| SEPT8 → SLITRK3 (>>) |
| SEPT8 → PCDHGA3///PCDHGA5///PCDHGA6///PCDHGA10///PCDHGA11///PCDHGA12 (>>) |
| SEPT8 → ZNF117 (>>) |
| SEPT8 → ELAVL4 (>>) |
| SEPT8 → KIAA0913///SAT1 (>>) |
| SEPT8 → PTCRA (>>) |
| SEPT8 → COMT (>>) |
| SEPT8 → OSM (>>) |
| SEPT8 → INPP4A (>>) |
| SEPT8 → FSHB (>>) |
| SEPT8 → NPHS1 (>>) |
| SEPT8 → B3GAT3 (>>) |
| SEPT8 → SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 (>>) |
| SEPT8 → CCDC88C (>>) |
| SEPT8 → CGGBP1 (>>) |
| SEPT8 → CACNG3 (>>) |
| SEPT8 → TMEM132A (>>) |
| SEPT8 → LOC100133772///SLC16A5 (>>) |
| SEPT8 → UBQLN4 (>>) |
| SEPT8 → MAPKBP1 (>>) |
| SEPT8 → CIZ1 (>>) |
| SEPT8 → NPDC1 (>>) |
| SEPT8 → UAP1L1 (>>) |
